Technical Analysis
Aurobindo Pharma has taken support at upper range of support box(630). It can move upwards after taking support at 630 price level. It is good time to accumulate share at current levels for long term.
Fundamental Analysis
Current PE : 7.45 (Undervalued in comparison to peer Pharma stocks)
Sector PE : 38.7
Below data for previous 5 years.
Revenue Growth : 15.2%
Sector Revenue Growth : 6.96%
Market share increased from 7.65% to 11%
Net income growth : 21.4%
Sector Net income growth : 8%
Aurobindo Pharma has taken support at upper range of support box(630). It can move upwards after taking support at 630 price level. It is good time to accumulate share at current levels for long term.
Fundamental Analysis
Current PE : 7.45 (Undervalued in comparison to peer Pharma stocks)
Sector PE : 38.7
Below data for previous 5 years.
Revenue Growth : 15.2%
Sector Revenue Growth : 6.96%
Market share increased from 7.65% to 11%
Net income growth : 21.4%
Sector Net income growth : 8%